絞り込み

16644

広告

ウミガメにセンサー 海水温長期予測の精度「劇的向上」 (NHK)

ウミガメに水温のセンサーを取り付けてデータを集め、長期的な海水温の予測の精度を高めるユニークな手法を海洋研究開発機構などが開発しました。 気象の長期的な予報には...

  1. 古代エジプト人が頭に載せた謎の物体、つい...
  2. 香港デモ半年、日本人写真家が見た若者たち...
  3. オスマン帝国の600年、巨大帝国はこうし...
  4. 15世紀末の歯ブラシに使われていた動物の...

ニュース一覧

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

著者 Ritchie C , Smailagic N , Noel-Storr AH , Takwoingi Y , Flicker L , Mason SE , McShane R
Cochrane Database Syst Rev.2014 Jun 10 ; 6():CD008782.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (226view , 0users)

Full Text Sources

Medical

Miscellaneous

Other Literature Sources

According to the latest revised National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association) (NINCDS-ADRDA) diagnostic criteria for Alzheimer's disease dementia of the National Institute on Aging and Alzheimer Association, the confidence in diagnosing mild cognitive impairment (MCI) due to Alzheimer's disease dementia is raised with the application of biomarkers based on measures in the cerebrospinal fluid (CSF) or imaging. These tests, added to core clinical criteria, might increase the sensitivity or specificity of a testing strategy. However, the accuracy of biomarkers in the diagnosis of Alzheimer's disease dementia and other dementias has not yet been systematically evaluated. A formal systematic evaluation of sensitivity, specificity, and other properties of plasma and CSF amyloid beta (Aß) biomarkers was performed.
PMID: 24913723 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード